Browsing Over 92 Presentations

Sort By Presentation Number
Biomarker development

15P - Tumor PD-L1 expression and blood biomarkers of activity of adaptive immunity and tumor microenvironment in patients with solid tumors

Room
e-Poster Display
Speakers
  • A. Malkova (Saint-Petersburg, Russian Federation)
Authors
  • A. Malkova (Saint-Petersburg, Russian Federation)
  • R. Orlova (Saint-Petersburg, Russian Federation)
  • N. Zhukova (Saint-Petersburg, Russian Federation)
  • V. Sharoyko (Saint-Petersburg, Russian Federation)
  • E. Kaledina (Saint-Petersburg, Russian Federation)
  • A. Gubal (Saint-Petersburg, Russian Federation)
Biomarker development

16P - PD-1/PD-L1 expression in Uveal Melanoma: Prognostic significance with tumor-infiltrating lymphocytes and clinicopathological parameters

Room
e-Poster Display
Speakers
  • L. Singh (New Delhi, Delhi, India)
Authors
  • L. Singh (New Delhi, Delhi, India)
  • M. Singh (New Delhi, India)
  • M. Rizvi (New Delhi, India)
  • S. Kashyap (New Delhi, India)
Biomarker development

17P - Effects of tumor mutation burden on the antigen presentation pathway

Room
e-Poster Display
Speakers
  • E. Garcia-Rivera (Rochester, MN, United States of America)
Authors
  • E. Garcia-Rivera (Rochester, MN, United States of America)
  • J. Park (Rochester, MN, United States of America)
  • C. Truntzer (Dijon, France)
  • F. Ghiringhelli (Dijon, France)
  • A. Mansfield (Rochester, MN, United States of America)
Biomarker development

18P - Influence of local immunity on the prognosis of gastric cancer.

Room
e-Poster Display
Speakers
  • G. Khakimova (Moscow, Russian Federation)
Authors
  • G. Khakimova (Moscow, Russian Federation)
Biomarker development

19P - Tumor microenvironment and radiomics landscape associated with survival and prediction of immunotherapy in patients with cancer

Room
e-Poster Display
Speakers
  • W. Zhang (Zhanjiang, China)
Authors
  • W. Zhang (Zhanjiang, China)
  • A. Li (Zhanjiang, China)
  • Y. Chen (Guangzhou, China)
  • Q. Ou (Guangzhou, China)
  • W. Ren (Guangzhou, China)
  • Z. He (Guangzhou, China)
  • Y. Yu (Guangzhou, China)
  • H. Yao (Guangzhou, China)
Biomarker development

20P - Quantitative whole slide assessment of CD8+ tumor-infiltrating lymphocytes in small cell esophageal carcinoma in relation to clinical outcome

Room
e-Poster Display
Speakers
  • Z. Zhang (Beijing, China)
Authors
  • Z. Zhang (Beijing, China)
  • C. Zhang (Beijing, China)
  • G. Zhang (Beijing, China)
  • L. Xue (Beijing, China)
  • Q. Zeng (Beijing, China)
  • L. Yue (Beijing, China)
  • Q. Xue (Beijing, China)
  • S. Gao (Beijing, China)
  • N. Sun (Beijing, China)
  • J. He (Beijing, China)
Biomarker development

21P - Characteristics of the lymphocytic infiltrate in breast cancer

Room
e-Poster Display
Speakers
  • W. Ben Kridis (Sfax, Tunisia)
Authors
  • W. Ben Kridis (Sfax, Tunisia)
  • L. Bouzidi (sfax, Tunisia)
  • S. Charfi (sfax, Tunisia)
  • H. Triki (sfax, Tunisia)
  • B. Cherif (sfax, Tunisia)
  • A. Rebai (sfax, Tunisia)
  • K. Chaaben (sfax, Tunisia)
  • T. Boudawara (sfax, Tunisia)
  • J. Daoud (sfax, Tunisia)
  • A. Khanfir (sfax, Tunisia)
Biomarker development

22P - Dynamics of indicators of the immune status in patients with metastatic solid tumors on the background of stereotactic ablative radiation therapy

Room
e-Poster Display
Speakers
  • A. Zozulya (Saint-Petersburg, Russian Federation)
Authors
  • A. Zozulya (Saint-Petersburg, Russian Federation)
  • I. Baldueva (Saint-Petersburg, Russian Federation)
  • S. Novikov (Saint-Petersburg, Russian Federation)
  • D. Girdyuk (Saint-Petersburg, Russian Federation)
  • N. Emelyanova (Saint-Petersburg, Russian Federation)
  • E. Tyuryaeva (Saint-Petersburg, Russian Federation)
  • E. Fedosova (Saint-Petersburg, Russian Federation)
  • P. Antipov (Saint-Petersburg, Russian Federation)
  • A. Arseniev (Saint-Petersburg, Russian Federation)
  • S. Kanaev (Saint-Petersburg, Russian Federation)
  • A. Belyaev (Saint-Petersburg, Russian Federation)
Cell therapy

25P - Improving efficacy and reducing toxicity of anti-PD-L1 treatment – T cells as delivery vehicles for anti-PD-L1 blocking nanobodies

Room
e-Poster Display
Speakers
  • P. Petit (Brussels, Belgium)
Authors
  • P. Petit (Brussels, Belgium)
  • J. Zhu (Brussels, Belgium)
  • B. Van den Eynde (Brussels, Belgium)
Cell therapy

26P - Cellulose Beads Prepared in Deep Eutectic Solvent Function as Carrier and Cytoprotective Encapsulation Matrix for CAR-T Cells in T-Cell Therapy against Glioblastoma Cells

Room
e-Poster Display
Speakers
  • S. Vuoti (Jyvaskyla, Finland)
Authors
  • S. Vuoti (Jyvaskyla, Finland)
  • M. Saari (Kauhava, Finland)
  • K. Narasimha (Kauhava, Finland)
  • K. Reinikainen (Kauhava, Finland)
Cell therapy

27P - Methodology for identification of clinically relevant targets for TCR-immunotherapy in hepatocellular carcinoma

Room
e-Poster Display
Speakers
  • P. Maravelia (Huddinge, Sweden)
Authors
  • P. Maravelia (Huddinge, Sweden)
  • A. Potti (Huddinge, Sweden)
  • D. Silva (Huddinge, Sweden)
  • T. Sekine (Huddinge, Sweden)
  • K. Healy (Huddinge, Sweden)
  • M. Chrobok (Huddinge, Sweden)
  • C. Jorns (Stockholm, Sweden)
  • M. Sällberg (Huddinge, Sweden)
  • M. Buggert (Huddinge, Sweden)
  • A. Pasetto (Huddinge, Sweden)
Cell therapy

28P - Helping the killers: innovative cancer immunotherapy harnessing quasi-universal tumor antigen-specific CD4 T cells

Room
e-Poster Display
Speakers
  • M. Saillard (Lausanne, Switzerland)
Authors
  • M. Saillard (Lausanne, Switzerland)
  • A. Cachot (Lausanne, Switzerland)
  • A. Rockinger (Epalinges, Switzerland)
  • P. Guillaume (Lausanne, Switzerland)
  • J. Schmidt (Lausanne, Switzerland)
  • A. Harari (Lausanne, Switzerland)
  • C. Jandus (Lausanne, Switzerland)
  • P. Romero (Epalinges, Switzerland)